TScan Therapeutics, Inc (TCRX) Price 6.7M Share IPO at $15/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
TScan Therapeutics, Inc (TCRX) IPO Opens 20% Lower
July 16, 2021 11:38 AM EDTToday's IPO for TScan Therapeutics, Inc (NYSE: TCRX) opened for trading at $12 after pricing 6,666,667 shares of common stock at a public offering price of $15.00 per share.
Morgan Stanley, Jefferies, Cowen and Barclays are acting as Joint Book-running Managers for the offering.
TScan is... More
